Minh Thu Luu
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Chronic Myeloid Leukemia Treatments, TGF-β signaling in diseases, Protein Kinase Regulation and GTPase Signaling, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Outgrowth of Drug-Resistant Carcinomas Expressing Markers of Tumor Aggression after Long-term TβRI/II Kinase Inhibition with LY2109761(2011)81 cited
- → Mouse and human strategies identify PTPN14 as a modifier of angiogenesis and hereditary haemorrhagic telangiectasia(2012)67 cited
- → Epistatic interactions between modifier genes confer strain-specific redundancy for Tgfb1 in developmental angiogenesis(2004)27 cited
- → INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY(2005)5 cited
- → Erratum: Mouse and human strategies identify PTPN14 as a modifier of angiogenesis and hereditary haemorrhagic telangiectasia(2012)1 cited
- → Supplementary Figures 1-6, Tables 1-5 from Outgrowth of Drug-Resistant Carcinomas Expressing Markers of Tumor Aggression after Long-term TβRI/II Kinase Inhibition with LY2109761(2023)
- → Characterization of Tgfbm2 , a genetic modifier of Tgfb1 −/− embryonic lethality.(2007)
- → Data from Outgrowth of Drug-Resistant Carcinomas Expressing Markers of Tumor Aggression after Long-term TβRI/II Kinase Inhibition with LY2109761(2023)